中国创新药卷出新高度，出海引领新发展

中国在创新药领域上的国际地位正急剧上升，以ADC（Antibody-Drug Conjugate，抗体药物偶联物）为代表的靶向药物更成为出海的主力军——这是《华夏时报》记者从第八届中国精准医疗大会上获得的信息。
New Jersey Business Magazine

Merck to Acquire Cidara Therapeutics, Inc. for $9.2 Billion

Merck and Cidara Therapeutics, Inc., have entered into a definitive agreement under which Merck will acquire Cidara for $9.2 ...
The Clinton Herald

SAVVY SENIOR: Understanding Social Security spousal benefits

Send your senior questions to: Savvy Senior, P.O. Box 5443, Norman, OK 73070, or visit SavvySenior.org. Jim Miller is a ...
The Reporter

ZUGZWANG: The Un-Silence of the Synthetic Self

Sunday. Post-lunch. The atmosphere was pure, low-grade tension. Write or stroll. That was the whole setup. The writing urge was bugging me; the whole day an ...
eLife

Nanoscopy Reveals Heparan Sulfate Clusters as Docking Sites for SARS-CoV-2 Attachment and Entry

Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...
BioWorld

Merck buys Cidara for $9.2B as Keytruda patent loss looms

Merck & Co. Inc. is buying Cidara Therapeutics Inc. for $9.2 billion to acquire a late-stage flu candidate and also to outrace blockbuster Keytruda’s looming patent expiration. CD-388, Cidara’s lead ...